PEAK6 Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.18M Sell
62,300
-1,400
-2% -$115K 0.01% 1044
2024
Q2
$7.22M Sell
63,700
-67,000
-51% -$8.47M 0.02% 653
2024
Q1
$18.1M Buy
130,700
+37,700
+41% +$4.74M 0.05% 318
2023
Q4
$11.5M Buy
93,000
+14,900
+19% +$1.52M 0.04% 421
2023
Q3
$7.29M Sell
78,100
-10,700
-12% -$1.21M 0.03% 531
2023
Q2
$11.4M Buy
88,800
+37,000
+71% +$4.48M 0.05% 325
2023
Q1
$6.02M Buy
51,800
+8,900
+21% +$996K 0.03% 620
2022
Q4
$4.86M Buy
42,900
+9,900
+30% +$1.09M 0.03% 741
2022
Q3
$2.66M Sell
33,000
-125,600
-79% -$10.6M 0.01% 1309
2022
Q2
$16.6M Buy
158,600
+66,600
+72% +$6.08M 0.03% 559
2022
Q1
$11.8M Sell
92,000
-132,812
-59% -$14.5M 0.03% 624
2021
Q4
$30.2M Sell
224,812
-131,988
-37% -$19M 0.06% 293
2021
Q3
$48.8M Sell
356,800
-129,200
-27% -$16.3M 0.11% 160
2021
Q2
$51.9M Buy
486,000
+330,800
+213% +$31.8M 0.12% 137
2021
Q1
$13.9M Sell
155,200
-141,600
-48% -$13.3M 0.03% 483
2020
Q4
$27.4M Buy
296,800
+214,800
+262% +$19.2M 0.06% 305
2020
Q3
$8.45M Sell
82,000
-26,800
-25% -$2.8M 0.02% 671
2020
Q2
$11M Buy
+108,800
New +$9.73M 0.04% 448
2020
Q1
Sell
-102,400
Closed -$5.6M 4094
2019
Q4
$5.6M Sell
102,400
-84,800
-45% -$4.02M 0.03% 582
2019
Q3
$6.98M Buy
187,200
+134,400
+255% +$5.22M 0.04% 517
2019
Q2
$1.98M Buy
+52,800
New +$1.66M 0.01% 1297

Other funds holding DXCM

PEAK6 Investments's DXCM Position: Q3 2024 in Review

PEAK6 Investments sold out of DexCom (DXCM) in Q3 2024, closing a stake of 1,890 shares — an estimated $155K sold.

PEAK6 Investments first reported a position in DXCM in Q1 2020 and held it in 9 quarters. The position peaked at $4.94M in Q4 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • PEAK6 Investments reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 1,890 DexCom shares in Q3 2024, an estimated $155K.
  • PEAK6 Investments first reported a position in DexCom in Q1 2020 and held it in 9 quarters.
  • PEAK6 Investments's DexCom position peaked at $4.94M in Q4 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.